Psychedelic Business Spotlight: July 23, 2021
Business, Stock Reports
This week in psychedelic business news: Psychedelics as a treatment for obesity and TBIs, plus another psychedelic company inches toward listing on NYSE American stock exchange.
Talking about MM-110, in May company announced Phase 2 will commence in Q2 2022. Q2 is over, but no announcement to this effect yet. Also, why on company webpage do they show MM-110 already in Phase 2?